HES
40
-3
PM
83
4
NOV
28
-4
L
54
2
M
28
-3
WDC
61
-2
RF
58
-2
PYPL
66
-4
CMI
55
-3
HST
32
-2
DD
33
-4
TEL
72
-2
PPL
67
3
PGR
62
5
KR
61
2
D
50
4
CA
18
6
AME
72
-2
FMC
33
-4
ABT
65
2
HES
40
-3
PM
83
4
NOV
28
-4
L
54
2
M
28
-3
WDC
61
-2
RF
58
-2
PYPL
66
-4
CMI
55
-3
HST
32
-2
DD
33
-4
TEL
72
-2
PPL
67
3
PGR
62
5
KR
61
2
D
50
4
CA
18
6
AME
72
-2
FMC
33
-4
ABT
65
2
Financhill
Back

Seres Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16

MCRB
Seres Therapeutics

Last Price:
$7.05
Seasonality Move:
31.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Seres Therapeutics Stock Forecast

  • Over the next 52 weeks, Seres Therapeutics has on average historically risen by 0.6% based on the past 9 years of stock performance.
  • Seres Therapeutics has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Seres Therapeutics Stock Undervalued?
    The current Seres Therapeutics [MCRB] share price is $7.05. The Score for MCRB is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • MCRB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Seres Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Seres Therapeutics has on average historically risen by 0.6% based on the past 9 years of stock performance.

Seres Therapeutics Stock Rating

Sell
16
Seres Therapeutics (MCRB) is a Sell

Is Seres Therapeutics overpriced?

  • Seres Therapeutics has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Seres Therapeutics Stock Price History

Is MCRB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
serestherapeutics.com

52-Week Data

52-Week High:
30.60
52-Week Low:
6.53

Prediction Charts

Market Cap:
61.6M
Price in USD:
7.05
Volume:
88.7K
Beta:
2.08

Technical Analysis

SMA50:
9.99
SMA100:
12.89
SMA200:
15.00
52-Wk Change:
-63.81%

Stock Predictions

  • Is Seres Therapeutics stock public?
    Yes, Seres Therapeutics is a publicly traded company.
  • What is the Seres Therapeutics stock quote today?
    The Seres Therapeutics stock price is 7.05 USD today.
  • How to buy Seres Therapeutics stock online?
    You can buy Seres Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-12 7.15 7.88 8.09 7.15
May-13 7.87 7.37 7.88 7.31
May-14 7.50 6.77 7.60 6.75
May-15 7.00 7.41 7.69 6.53
May-16 7.28 7.46 7.55 7.14
May-19 7.46 7.98 8.31 7.34
May-20 7.94 8.24 8.33 7.73
May-21 8.09 7.70 8.33 7.70
May-22 7.54 7.44 7.76 7.32
May-23 7.34 7.67 7.86 7.34
May-27 7.79 7.23 7.79 7.11
May-28 7.31 7.05 7.31 7.00
May-29 7.02 7.09 7.16 6.92
May-30 7.02 7.05 7.33 6.84

Seres Therapeutics Earnings

Seres Therapeutics Earnings Report: Per Share Seres Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Seres Therapeutics Forecast Revenue Growth

Seres Therapeutics Stock Analysis: Historical quarterly revenues per share for Seres Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $2.58 per share, an increase this year of $4.60 per share, and a decrease next year of $1.43 per share.

* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.